Novartis AG

Novartis raises 2023 view, after posting higher profit and sales

1:44 a.m. April 25, 2023

- Cecilia Butini

Novartis shares jump after positive result from breast-cancer drug trial

7:07 a.m. March 27, 2023

- Cecilia Butini

Novartis posts lower sales and profit on generic competition, but boosts 2022 dividend

2:39 a.m. Feb. 1, 2023

- Cecilia Butini

Novartis earnings and sales fall short of expectations, but backs 2022 view

1:34 a.m. Oct. 25, 2022

- Cecilia Butini

Novartis outlines plan to become a 'top-five player' in U.S. pharmaceuticals market

8:58 a.m. Sept. 23, 2022

- Jaimy Lee

AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts say

7:48 a.m. Sept. 14, 2022

- Anviksha Patel

Fed heroics or no, the S&P 500 level is destined for a retest of lows. These are the levels to watch, says this strategist

9:59 a.m. Aug. 25, 2022

- Barbara Kollmeyer

Novartis suspends delivery of cancer treatment as it address potential production issues

1:37 p.m. May 5, 2022

- Tomi Kilgore

This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst

10:14 a.m. March 22, 2022

- Barbara Kollmeyer

AT&T and 4 more unloved dividend stocks to buy in a ‘risk-off’ era

9:28 a.m. Feb. 1, 2022

- Jeff Reeves

European stocks led lower by techs, on rate concerns and Atos warning

9:58 a.m. Jan. 10, 2022

- Steve Goldstein

Europe stocks beat back omicron worries to rise alongside global stocks

11:42 a.m. Dec. 23, 2021

- Barbara Kollmeyer

European stocks slide as COVID worries swamp investors

10:29 a.m. Dec. 20, 2021

- Barbara Kollmeyer

Europe stocks head for a fresh record close, led by Roche and oil giants

10:18 a.m. Nov. 4, 2021

- Barbara Kollmeyer

Europe stocks off highs as Deutsche Bank slides after results

10:51 a.m. Oct. 27, 2021

- Barbara Kollmeyer

European stocks slump as worries spread about COVID’s global growth

9:20 a.m. Sept. 8, 2021

- Barbara Kollmeyer

WHO to study whether three drugs, including J&J's Remicade, can help hospitalized COVID-19 patients

7:50 a.m. Aug. 12, 2021

- Jaimy Lee

Rebound from Monday’s rout continues for European stocks

9:58 a.m. July 21, 2021

- Barbara Kollmeyer

European stocks rebound from sharp selloff

10:08 a.m. July 9, 2021

- Barbara Kollmeyer

European stocks struggle at the end of the week

10:15 a.m. June 25, 2021

- Barbara Kollmeyer

Digital Pills That Talk to Your Doctor Are Here

2:00 p.m. Nov. 14, 2017

- The Wall Street Journal Interactive Edition

Trump’s Regulators Aim to Boost Growth by Fostering Innovation

8:23 p.m. Oct. 25, 2017

- The Wall Street Journal Interactive Edition

Business Watch: News Digest

10:25 p.m. May 7, 2015

- The Wall Street Journal Interactive Edition

GSK’s Sturdy Strategy Leaves Investors Waiting

1:33 p.m. May 6, 2015

- The Wall Street Journal Interactive Edition

GSK Cuts Return to Shareholders From Novartis Deal

12:33 p.m. May 6, 2015

- The Wall Street Journal Interactive Edition

Novartis Sees Benefits of Overhaul

5:52 a.m. April 23, 2015

- The Wall Street Journal Interactive Edition

Bristol-Myers Invests in uniQure in Heart-Disease Pact

11:04 p.m. April 6, 2015

- The Wall Street Journal Interactive Edition

Bayer CEO Injects a Dose of U.S. Risk-Taking

2:15 p.m. April 7, 2015

- The Wall Street Journal Interactive Edition

Swiss Companies Battle Strong Franc

11:52 a.m. March 2, 2015

- The Wall Street Journal Interactive Edition

Novartis Japan Ordered to Shut Down 15 Days

12:59 p.m. Feb. 27, 2015

- The Wall Street Journal Interactive Edition

Novartis Amends Heart-Drug Trial

8:32 p.m. Feb. 27, 2015

- The Wall Street Journal Interactive Edition

New Cancer Technology Cheers Investors

4:35 p.m. Feb. 23, 2015

- The Wall Street Journal Interactive Edition

Ten Billion Dollar Ideas You’ve Never Heard Of

3:24 p.m. Feb. 23, 2015

- The Wall Street Journal Interactive Edition

CSL Shaves Guidance as Competition Heats Up

2:11 a.m. Feb. 11, 2015

- The Wall Street Journal Interactive Edition

Cheap Swiss-Franc Bond Entices Apple

3:34 p.m. Feb. 10, 2015

- The Wall Street Journal Interactive Edition

Drug Making Breaks Away From Old Ways

2:32 a.m. March 9, 2015

- The Wall Street Journal Interactive Edition

Pfizer to Buy Hospira for $16 Billion

11:22 a.m. Feb. 6, 2015

- The Wall Street Journal Interactive Edition

Glaxo Is Still in the Recovery Room

1:58 p.m. Feb. 4, 2015

- The Wall Street Journal Interactive Edition

Investors Shouldn’t Fight QE Drag on Corporate Bonds

3:31 a.m. March 5, 2015

- The Wall Street Journal Interactive Edition

Glaxo Posts Sharp Fall in Profit

1:28 p.m. Feb. 4, 2015

- The Wall Street Journal Interactive Edition